How long each pen lasts depends on the dose you take
Potential interactions are poorly studied
Final Thoughts GLP-1 agonists represent an interesting and evolving area of research in autoimmune care, particularly due to their effects on metabolic health
Fasting insulin levels significantly decreased with tirzepatide (10 mg and 15 mg), and HOMA2-IR, a measure of insulin resistance, significantly decreased with tirzepatide (10 mg) compared to both placebo and dulaglutide
People who take GLP-1 medications for several years may face a higher risk of developing osteoporosis, gout, and osteomalacia, according to new research presented Monday at the annual meeting of the American Academy of Orthopaedic Surgeons
For nebulizer treatments, 2.5 mg every 4 to 6 hours is typical